[1]
R. W. Dal Negro, P. Turco, and M. Povero, “Nebivolol: an effective option against long-lasting dyspnoea following COVID-19 pneumonia - a pivotal double-blind, cross-over controlled study”, Multidiscip Respir Med, vol. 17, Dec. 2022, doi: 10.4081/mrm.2022.886.